A new lab system tracks damage and repair in tiny, lab-grown models of the human gut lining. The 2026 study in Cell Reports Methods tested human tissue models, not treatments in people. These models are called organoids. They let researchers study how the gut lining responds to inflammation. The system can test many models while tracking each one separately. Researchers exposed the models to a mix of signals that cause inflammation. They then tracked changes in shape, gene activity, and leaks through the lining. Some gene changes resembled those found in gut tissue from people with Crohn’s disease. This suggests the models capture some features of the disease, not the whole condition. Three substances improved recovery in the models: dexamethasone, a medicine that reduces inflammation; nicotinamide, a form of vitamin B3; and beta-hydroxybutyrate, a fuel the body makes from fat. The first two affected different cell processes tied to inflammation and the gut barrier. The supplied summary gives no effect sizes or recovery percentages. For this community, the two recovery scores are different measures. The study used a score for repair in lab-grown gut tissue. It did not test the Recovery Score members track or connect that number to gut healing. The takeaway is a better way to study gut repair, not a proven recovery habit. When comparing your own numbers with the community, keep symptoms and score trends distinct. This study cannot show whether they move together. What have you noticed when comparing your Recovery Score with how your gut feels?